← Open Payments lookup

ZACHARY GIBSON: Open Payments

NPI 1619566833 · SALEM, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$267 in 14 payments from 11 companies in 2025. Trend: 2023 $701 · 2024 $332 · 2025 $267

Food & beverage: $267
CompanyPaymentsAmount
ABBVIE INC.3$64
Novo Nordisk Inc2$36
Novartis Pharmaceuticals Corporation1$26
Axsome Therapeutics, Inc.1$25
Amgen Inc.1$20
Supernus Pharmaceuticals, Inc.1$18
Bayer Healthcare Pharmaceuticals Inc.1$18
Merck Sharp & Dohme LLC1$17
Aimmune Therapeutics, Inc.1$15
Otsuka America Pharmaceutical, Inc.1$15

Products named: VRAYLAR, Wegovy, LEQVIO, Auvelity, OTEZLA, Qelbree, Kerendia, GARDASIL 9.

Industry payments across UT — which companies pay providers there.